Clinical trial / 2005
A reduced microparticle diet did not improve remission or clinical response in patients with active Crohn's disease.
Eighty-three patients with active Crohn's disease were randomized in a 2 x 2 factorial design to a diet low or normal in microparticles and/or calcium for 16 weeks, alongside a tapering 6-week prednisolone regimen, followed by 36 weeks on a normal diet. Dietary manipulation provided no added benefit over corticosteroid treatment on any outcome measure during the 16-week intervention or up to 1-year follow-up. For example, logistic regression showed no significant difference between normal and low microparticle groups for Crohn's disease activity index-based rates of remission (P=0.1) or clinical response (P=0.8).
- Study type
- Single-blind, randomized, multicenter, placebo-controlled 2x2 factorial trial
- Who was studied
- 83 patients with active Crohn's disease
- What was measured
- Crohn's disease activity index, Van Hees index, quality of life, and inflammatory measures
THE PAPER
Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease.
Lomer MC, Grainger SL, Ede R, Catterall AP, Greenfield SM, Cowan RE, Vicary FR, Jenkins AP, Fidler H, Harvey RS, Ellis R, McNair A, Ainley CC, Thompson RP, Powell JJ. Eur J Gastroenterol Hepatol, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.